1. Home
  2. CSWI vs GKOS Comparison

CSWI vs GKOS Comparison

Compare CSWI & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSWI
  • GKOS
  • Stock Information
  • Founded
  • CSWI 2014
  • GKOS 1998
  • Country
  • CSWI United States
  • GKOS United States
  • Employees
  • CSWI N/A
  • GKOS N/A
  • Industry
  • CSWI Home Furnishings
  • GKOS Medical/Dental Instruments
  • Sector
  • CSWI Industrials
  • GKOS Health Care
  • Exchange
  • CSWI Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • CSWI 5.6B
  • GKOS 5.1B
  • IPO Year
  • CSWI N/A
  • GKOS 2015
  • Fundamental
  • Price
  • CSWI $301.20
  • GKOS $94.79
  • Analyst Decision
  • CSWI Buy
  • GKOS Strong Buy
  • Analyst Count
  • CSWI 4
  • GKOS 13
  • Target Price
  • CSWI $342.00
  • GKOS $135.15
  • AVG Volume (30 Days)
  • CSWI 98.0K
  • GKOS 822.7K
  • Earning Date
  • CSWI 05-22-2025
  • GKOS 04-30-2025
  • Dividend Yield
  • CSWI 0.32%
  • GKOS N/A
  • EPS Growth
  • CSWI 28.53
  • GKOS N/A
  • EPS
  • CSWI 8.38
  • GKOS N/A
  • Revenue
  • CSWI $878,301,000.00
  • GKOS $404,523,000.00
  • Revenue This Year
  • CSWI $13.97
  • GKOS $27.89
  • Revenue Next Year
  • CSWI $6.79
  • GKOS $27.57
  • P/E Ratio
  • CSWI $36.49
  • GKOS N/A
  • Revenue Growth
  • CSWI 10.78
  • GKOS 23.92
  • 52 Week Low
  • CSWI $248.90
  • GKOS $77.10
  • 52 Week High
  • CSWI $436.50
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • CSWI 43.30
  • GKOS 51.03
  • Support Level
  • CSWI $297.25
  • GKOS $93.52
  • Resistance Level
  • CSWI $314.56
  • GKOS $101.57
  • Average True Range (ATR)
  • CSWI 9.60
  • GKOS 3.41
  • MACD
  • CSWI -3.03
  • GKOS 0.30
  • Stochastic Oscillator
  • CSWI 9.48
  • GKOS 46.06

About CSWI CSW Industrials Inc.

CSW Industrials Inc is a diversified industrial growth company with well-established, scalable platforms and domain expertise across three segments, Contractor Solutions, Engineered Building Solutions, and Specialized Reliability Solutions. The company's Contractor Solutions segment involves manufacturing efficient and performance-enhancing products for residential and commercial HVAC/R and plumbing applications, which are designed for professional end-use customers. Majority of the company revenue is generated from Contractor Solutions segment from U.S. markets.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: